1. Home
  2. SRPT vs FULTP Comparison

SRPT vs FULTP Comparison

Compare SRPT & FULTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • FULTP
  • Stock Information
  • Founded
  • SRPT 1980
  • FULTP N/A
  • Country
  • SRPT United States
  • FULTP United States
  • Employees
  • SRPT N/A
  • FULTP 3400
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • FULTP Major Banks
  • Sector
  • SRPT Health Care
  • FULTP Finance
  • Exchange
  • SRPT Nasdaq
  • FULTP Nasdaq
  • Market Cap
  • SRPT N/A
  • FULTP N/A
  • IPO Year
  • SRPT 1997
  • FULTP N/A
  • Fundamental
  • Price
  • SRPT $17.67
  • FULTP $18.05
  • Analyst Decision
  • SRPT Buy
  • FULTP
  • Analyst Count
  • SRPT 25
  • FULTP 0
  • Target Price
  • SRPT $64.00
  • FULTP N/A
  • AVG Volume (30 Days)
  • SRPT 7.7M
  • FULTP N/A
  • Earning Date
  • SRPT 08-06-2025
  • FULTP N/A
  • Dividend Yield
  • SRPT N/A
  • FULTP N/A
  • EPS Growth
  • SRPT N/A
  • FULTP N/A
  • EPS
  • SRPT N/A
  • FULTP N/A
  • Revenue
  • SRPT $2,233,371,000.00
  • FULTP N/A
  • Revenue This Year
  • SRPT $26.87
  • FULTP N/A
  • Revenue Next Year
  • SRPT $3.15
  • FULTP N/A
  • P/E Ratio
  • SRPT N/A
  • FULTP N/A
  • Revenue Growth
  • SRPT 59.15
  • FULTP N/A
  • 52 Week Low
  • SRPT $16.88
  • FULTP N/A
  • 52 Week High
  • SRPT $162.95
  • FULTP N/A
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 18.77
  • FULTP 48.15
  • Support Level
  • SRPT $18.30
  • FULTP $18.00
  • Resistance Level
  • SRPT $22.98
  • FULTP $18.26
  • Average True Range (ATR)
  • SRPT 1.43
  • FULTP 0.20
  • MACD
  • SRPT -0.49
  • FULTP 0.06
  • Stochastic Oscillator
  • SRPT 0.99
  • FULTP 75.00

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About FULTP Fulton Financial Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A

Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.

Share on Social Networks: